文献速递关节外科创伤骨科

骨科专科医院翻修髋膝关节置换的经济负担:成本更高与报销不均

Financial Burden of Revision Hip and Knee Arthroplasty at an Orthopedic Specialty Hospital: Higher Costs and Unequal Reimbursements.
PubMed 文献 · J Arthroplasty · 2021-03-23

该研究基于2018至2020年一家骨科专科医院的13946例关节置换术,采用时间驱动作业成本法分析翻修与初次全关节置换的植入物成本、总医院成本、报销与收入。结果显示翻修TJA的植入物成本占比和总医院成本均更高,但报销增幅不及成本增幅,利润率更低,提示当前报销模式可能限制翻修服务的可及性。

要点

  • 翻修TJA的DRG 468总医院成本比初次TJA的DRG 470高61.1%。
  • 翻修TJA的植入物成本占总医院成本的55.8%,高于初次TJA的43.6%。
  • 翻修TJA的报销仅为初次TJA的1.23倍,DRG 468利润率比DRG 470低1.5%。

核心结论

  • 翻修TJA比初次TJA需要更多医院资源和成本,但报销可能不足以覆盖提供最佳护理所需的额外支出。
  • 若医院无法在当前报销模式下开展翻修服务,患者可及性可能受限。
  • 植入物成本是翻修TJA总成本的主要贡献因素,需要策略降低翻修植入物成本以提升护理价值。

研究设计与样本

  • 研究为经济与决策分析,证据等级为Level III。
  • 采用时间驱动作业成本法,分析2018至2020年一家骨科专科医院所有初次和翻修TJA按DRG分组的平均植入物成本、总医院成本、报销和付款方类型。
  • 共纳入13946例关节置换术。

主要发现

  • 翻修TJA DRG 468的植入物成本占总医院成本的55.8%,初次TJA DRG 470为43.6%。
  • DRG 468的总医院成本比DRG 470多61.1%。
  • 翻修TJA的报销是初次TJA的1.23倍。
  • 私人付款方对翻修TJA的支付比Medicare多23.2%。
  • DRG 468的利润率比初次DRG 470低1.5%。

临床怎么用

  • 临床与医院管理应关注翻修TJA的植入物成本控制,以改善其经济可持续性。
  • 在捆绑支付模式下,需评估翻修TJA的报销是否充分覆盖其额外资源消耗。

局限性

  • 研究基于单一骨科专科医院2018至2020年的数据,结论外推需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As demand for primary total joint arthroplasty (TJA) continues to grow, a proportionate increase in revision TJA (rTJA) is expected. It is essential to understand costs and reimbursement of rTJA as our country moves to bundled payment models. We aimed (1) to characterize implant and total hospital costs, (2) assess reimbursement, and (3) determine revenue for rTJA in comparison with primary TJA. METHODS: The average implant and total hospital cost of all primary and rTJA procedures by diagnosis-related group (DRG) was calculated using time-driven activity-based costing at an orthopedic hospital from 2018 to 2020. Average reimbursement and payer type were assessed by DRG. Revenue was calculated by deducting average time-driven activity-based costing total costs from reimbursement. RESULTS: 13,946 arthroplasties were included in the study. Implant cost comprised 55.8% of total hospital costs for rTJA DRG 468, compared with 43.6% of total hospital costs for primary TJA DRG 470. Total hospital costs for DRG 468 were 61.1% more than DRG 470. Reimbursement for rTJA was 1.23x more than primary TJA. Private payers paid 23.2% more than Medicare for rTJA. Margin for DRG 468 was 1.5% less than primary DRG 470. CONCLUSION: rTJA requires more hospital resources and costs than primaries, yet hospital reimbursement may be inadequate with the additional expenditures necessary to provide optimal care. If hospitals cannot perform revision services under the current reimbursement model, patient access may be limited. Implant costs are a major contributor to overall rTJA cost. Strategies are needed to reduce revision implant costs to improve value of care. LEVEL OF EVIDENCE: Level III, economic and decision analysis.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Fang CJ, Shaker JM, Ward DM, et al. Financial Burden of Revision Hip and Knee Arthroplasty at an Orthopedic Specialty Hospital: Higher Costs and Unequal Reimbursements. J Arthroplasty. 2021. PMID: 33840537. doi:10.1016/j.arth.2021.03.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。